Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2005 | 11-2004 | 11-2003 | 11-2002 | 11-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,033 | 2,840 | -7,522 | -6,048 | 900 |
| Depreciation Amortization | 597 | 657 | 453 | 802 | 513 |
| Accounts receivable | -47 | -651 | -116 | 618 | -1,310 |
| Accounts payable and accrued liabilities | -4 | 142 | -51 | 276 | 22 |
| Other Working Capital | 1,522 | 769 | 3,139 | 1,459 | -955 |
| Other Operating Activity | 22 | 889 | 2,423 | 3,086 | 2,088 |
| Operating Cash Flow | $3,125 | $4,648 | $-1,674 | $193 | $1,258 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -683 | -2,236 | -70 | -1,138 | -667 |
| Purchase Of Investment | N/A | -619 | -300 | -3,080 | -300 |
| Sale Of Investment | 596 | 600 | 2,299 | N/A | 52 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -3 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -3 | -350 |
| Investing Cash Flow | $-87 | $-2,255 | $1,929 | $-4,221 | $-1,265 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 33 | 467 |
| Debt Issued | N/A | -145 | N/A | N/A | N/A |
| Debt Repayment | N/A | -89 | 29 | -46 | -9 |
| Common Stock Issued | 204 | 26 | N/A | 43 | 2,393 |
| Other Financing Activity | 0 | 101 | 232 | 393 | 0 |
| Financing Cash Flow | $204 | $-107 | $261 | $423 | $2,852 |
| Beginning Cash Position | 4,737 | 2,452 | 1,936 | 5,541 | 2,696 |
| End Cash Position | 7,979 | 4,737 | 2,452 | 1,936 | 5,541 |
| Net Cash Flow | $3,242 | $2,285 | $517 | $-3,605 | $2,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,125 | 4,648 | -1,674 | 193 | 1,258 |
| Capital Expenditure | -709 | -2,242 | -186 | -1,138 | -667 |
| Free Cash Flow | 2,416 | 2,405 | -1,860 | -945 | 591 |